|Videos|December 16, 2021
Dr. Mian highlights his SUO presentation on transperineal biopsy clinical trials
Author(s)Urology Times staff
“One center would report 0.5% infection after transrectal. Another colleague may report 10%. That's a huge gap. And we have to understand why that gap is. The only way to find out will be through these randomized, controlled trials,” says Badar M. Mian, MD, FACS.
Advertisement
In this video, Badar M. Mian, MD, FACS, discusses the key points of his presentation, “Clinical trials of TP biopsy,’ which was presented recently at the 2021 Society of Urologic Oncology Annual Meeting. Mian is a professor of surgery and urology at Albany Med Urology in Albany, New York.
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Related Content
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA grants clearance to Hugo robotic-assisted surgery system for urologic procedures
2
Apalutamide is linked to fewer CNS-related conditions in patients with nmCRPC
3
Prostate MRI is linked with higher sensitivity, NPV vs micro-ultrasound in pilot study
4
BOND-003: Cretostimogene yields durable 24-month responses in high-grade NMIBC
5
